The MarketReader Minute
💊 Biotech Blues: REGN, LEGN, and MRNA Face Analyst Downgrades and Sector Challenges | Biotech Sector Insights
The ETF's top holdings experienced significant declines, with Moderna Inc. and Regeneron Pharmaceuticals receiving Underperform ratings from BofA Securities, alongside price targets suggesting further downside.